NFKB1 and rheumatoid arthritis: Varani et al. showed [28] that A2AR was upregulated in lymphocytes from early RA patients and A2AR activation inhibited the NF-kB pathway and decreased the expression of inflammatory cytokines such as TNF-α, IL-1β, and IL-6.